Imperial College London

Professor Peter Barnes, FRS

Faculty of MedicineNational Heart & Lung Institute

Margaret Turner-Warwick Chair
 
 
 
//

Contact

 

+44 (0)20 7594 7959p.j.barnes Website

 
 
//

Assistant

 

Miss Carolyn Green +44 (0)20 7594 7959

 
//

Location

 

227CGuy Scadding BuildingRoyal Brompton Campus

//

Summary

 

External Positions

  • Member, Steering Committee, Biomedical Alliance, 2011
  • Member, Sectional Committee 10, Royal Society, 2010 - 2013
  • Scientific Committee, WHO/NIH GINA Guidelines (Asthma), 2001
  • Scientific Committee, WHO/NIH GOLD Guidelines (COPD), 2001

Industrial Connections

  • Aerocrine, Scientific Advisory Board
  • Altana, Scientific Advisory Board, 5 years
  • Argenta, Scientific Advisory Board
  • Boehringer Ingelheim, Scientific Advisory Board, 5 years
  • Entelos Inc, Consultant
  • EpiGenesis Pharmaceuticals, Scientific Advisory Board
  • Etiologics, Scientific Advisory Board, 5 years
  • GlaxoSmithKline, Consultant
  • Millennium Pharmaceuticals, Scientific Advisory Board

Commercial Spinoffs

  • RespiVert, Co-founder, Imperial spin-out company developing novel inhaled anti-inflammatory therapies for steroid-resistant airway diseases, such as COPD, severe asthma snd cyctic fibrosis. Acquired by Johnson & Johnson in 2010., 2007

Fellowships

  • Master FCCP, American College of Chest Physicians, 2012
  • Member, Academia Europaea, 2012
  • Honorary Fellow, St Catharine's College Cambridge, 2011
  • Fellow, Royal Society, 2007
  • Fellow (Founding Fellow), Academy of Medical Sciences, 1998

Editorial Boards

  • Am J Respir Crit Care Med, Associate Editor, 2009 - 2014
  • Journal of COPD, Associate Editor, 2004
  • N Engl J Med, Editorial Board, 1994 - 2004
  • Postgrad Med J, Editorial Board, 1989 - 2005
  • Respiration, Editorial Board, 1990
  • Respiratory Research, Editor in Chief, 2000
  • Thorax, Editorial Board, 1992
  • Drugs, Editroial Board, 1990